Hannah Mcconkey
Latest contributions
What every interventional cardiologist should know about new cardiovascular drugs
Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to...
How to deal with unfavorable anatomy: TAVI or surgery?
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the optimal treatment stratgies for unfavorable anatomies, such as in an extremely horizontal aortic root, in calcified bicuspid aortic valves, and more!
Will the PARTNER 3 Low Risk trial change my practice?
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about the relevance of the PARTNER 3 Low Risk TAVI trial, how the results apply to specific patients and how they may impact your clinical practice.
